Hematology TimesCompounds can target Ras pathwayNovember 22, 2014Leukemia, Myelodysplasia, TransplantationRelated Issues
Hematology TimesFDA grants drug orphan designation for AMLNovember 21, 2014Leukemia, Myelodysplasia, TransplantationPharmacyAML
Hematology TimesInhibitor could transform AML therapy, speaker saysNovember 20, 2014Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesDiscovery reveals potential approach to treat CMLNovember 20, 2014Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesFDA grants CAR T-cell therapy orphan designationNovember 19, 2014Leukemia, Myelodysplasia, TransplantationPharmacyALL
The Journal of Community and Supportive OncologyCongestive heart failure during induction with anthracycline-based therapy in patients with acute promyelocytic leukemiaNovember 17, 2014Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
The Journal of Community and Supportive OncologyA wonderful lifeNovember 17, 2014Patient & Survivor CareLeukemia, Myelodysplasia, TransplantationHead & Neck/Thyroid CancersLung CancerFollicular Lymphoma
Hematology TimesBlood sample storage may hinder leukemia researchNovember 12, 2014Leukemia, Myelodysplasia, Transplantation
Hematology TimesHospice cuts cost and use of care for cancer patientsNovember 12, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesCompounds could treat CML more effectivelyNovember 11, 2014Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesGroup develops cancer health literacy toolNovember 11, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesHematology drugs on the fast trackNovember 9, 2014CythemiasLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Oncology PracticeFDA panel votes against panobinostat as add-on therapy for multiple myelomaNovember 7, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology TimesRNAi therapy may eliminate resistance in B-ALLNovember 6, 2014Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesNICE recommends ofatumumab in CLLNovember 6, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
